| 000 | 00751 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250513061217.0 | ||
| 264 | 0 | _c19930602 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/0140-6736(93)93179-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeredith, P A | |
| 245 | 0 | 0 |
_aDrug safety. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMay 1993 |
||
| 300 |
_a1156 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAmlodipine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aElliott, H L | |
| 773 | 0 |
_tLancet (London, England) _gvol. 341 _gno. 8853 _gp. 1156 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0140-6736(93)93179-5 _zAvailable from publisher's website |
| 999 |
_c8097164 _d8097164 |
||